Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04262427
Title The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma (CAPER)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors The Christie NHS Foundation Trust

renal cell carcinoma


Cyclophosphamide + Pembrolizumab

Age Groups: senior | adult
Covered Countries

No variant requirements are available.